Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
BioCool AB
AB
Active
Org 5568848203
Malmskillnadsgatan 39, 111 38
Stockholm
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2012 · 14 years old
5 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
BioCool AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
21M
16M
11M
5M
0M
2020: 9M
9M
2020
2021: 12M (+33% vs 2020)
12M
+33%
2021
2022: 17M (+42% vs 2021)
17M
+42%
2022
2023: 9M (-47% vs 2022)
9M
-47%
2023
2024: 10M (+11% vs 2023)
10M
+11%
2024
EBITDA
SEK millions
0M
-4M
-7M
-11M
-15M
2020: -4M
-4M
2020
2021: -6M (-50% vs 2020)
-6M
-50%
2021
2022: -5M (+17% vs 2021)
-5M
+17%
2022
2023: -12M (-140% vs 2022)
-12M
-140%
2023
2024: -5M (+58% vs 2023)
-5M
+58%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
10 139
8 866
17 030
11 948
9 186
Staff expenses
—
—
—
—
—
EBITDA
−5 334
−11 827
−4 625
−5 865
−3 558
Depreciation & amort.
−2 763
−2 640
−2 606
−564
−682
EBIT
−8 097
−14 467
−7 231
−6 429
−4 240
Net financials
−141
−66
−68
−8
−226
Profit before tax
−8 238
−14 534
−7 299
−6 436
−4 465
Tax
−0
2 982
1 505
1 312
1 645
Net profit
−8 238
−11 552
−5 794
−5 124
−2 820
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
21 389
23 465
22 567
20 791
25 930
Equity
12 882
21 120
12 673
18 464
23 588
Long-term debt
0
0
8 000
0
0
Short-term debt
8 507
2 345
1 894
2 327
2 342
Total debt
8 507
2 345
9 894
2 327
2 342
Financial ratios
5-year trend
EBITDA margin
−52,6 %
This company
15,8 %
Market median
This company
Market median
433% below market
2020
2024
Equity ratio
60,2 %
This company
38,2 %
Market median
This company
Market median
58% above market
2020
2024
Return on equity
−63,9 %
This company
18,4 %
Market median
This company
Market median
447% below market
2020
2024
Net profit margin
−81,3 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2020
2024
Asset turnover
0,47×
This company
1,12×
Market median
This company
Market median
58% below market
2020
2024
Debt / equity
0,66×
This company
0,62×
Market median
This company
Market median
6% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on BioCool AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
